BioCentury
ARTICLE | Financial News

Acceleron amends IPO

September 9, 2013 7:00 AM UTC

Acceleron Pharma Inc., Cambridge, Mass. Business: Musculoskeletal, Hematology, Cancer Date announced: 8/7/13 Type: IPO To be raised: Up to $80.2 million Shares: 4.7 million Price: $13-$15 Underwriters...